Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 21 studies | 40% ± 15% | |
classical monocyte | 18 studies | 27% ± 10% | |
conventional dendritic cell | 15 studies | 32% ± 14% | |
monocyte | 9 studies | 26% ± 6% | |
macrophage | 9 studies | 20% ± 5% | |
plasmacytoid dendritic cell | 9 studies | 27% ± 7% | |
dendritic cell | 7 studies | 42% ± 12% | |
myeloid cell | 4 studies | 27% ± 6% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 2% | |
epithelial cell | 3 studies | 25% ± 3% | |
gamma-delta T cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 8 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3228.01 | 1444 / 1445 | 100% | 77.06 | 183 / 183 |
lung | 100% | 4904.95 | 578 / 578 | 100% | 59.43 | 1153 / 1155 |
intestine | 100% | 3067.24 | 966 / 966 | 100% | 72.28 | 526 / 527 |
bladder | 100% | 2526.81 | 21 / 21 | 100% | 73.90 | 503 / 504 |
breast | 100% | 2698.91 | 459 / 459 | 100% | 65.10 | 1113 / 1118 |
stomach | 99% | 2233.95 | 356 / 359 | 100% | 73.65 | 286 / 286 |
skin | 100% | 2825.70 | 1808 / 1809 | 99% | 56.96 | 467 / 472 |
ovary | 99% | 1806.22 | 178 / 180 | 100% | 55.92 | 429 / 430 |
prostate | 100% | 2305.14 | 245 / 245 | 99% | 39.15 | 495 / 502 |
uterus | 100% | 1962.19 | 170 / 170 | 98% | 54.95 | 452 / 459 |
thymus | 100% | 1924.26 | 652 / 653 | 98% | 34.47 | 592 / 605 |
liver | 100% | 3470.23 | 226 / 226 | 97% | 32.94 | 395 / 406 |
kidney | 100% | 1999.64 | 89 / 89 | 92% | 38.56 | 828 / 901 |
pancreas | 93% | 1230.67 | 305 / 328 | 99% | 65.81 | 176 / 178 |
adrenal gland | 100% | 2487.58 | 258 / 258 | 86% | 23.12 | 198 / 230 |
brain | 54% | 516.70 | 1421 / 2642 | 82% | 26.25 | 576 / 705 |
adipose | 100% | 3221.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 86.22 | 29 / 29 |
peripheral blood | 100% | 18450.50 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 8341.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.78 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.96 | 1 / 1 |
blood vessel | 97% | 1706.44 | 1300 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 19.06 | 72 / 80 |
heart | 86% | 981.21 | 740 / 861 | 0% | 0 | 0 / 0 |
muscle | 11% | 83.28 | 87 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007254 | Biological process | JNK cascade |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0032747 | Biological process | positive regulation of interleukin-23 production |
GO_0038172 | Biological process | interleukin-33-mediated signaling pathway |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0006909 | Biological process | phagocytosis |
GO_0008063 | Biological process | Toll signaling pathway |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0043200 | Biological process | response to amino acid |
GO_1902622 | Biological process | regulation of neutrophil migration |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_0032494 | Biological process | response to peptidoglycan |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0050671 | Biological process | positive regulation of lymphocyte proliferation |
GO_0016064 | Biological process | immunoglobulin mediated immune response |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0010467 | Biological process | gene expression |
GO_0043588 | Biological process | skin development |
GO_0034158 | Biological process | toll-like receptor 8 signaling pathway |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_2000338 | Biological process | regulation of chemokine (C-X-C motif) ligand 1 production |
GO_0045471 | Biological process | response to ethanol |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0060907 | Biological process | positive regulation of macrophage cytokine production |
GO_0090557 | Biological process | establishment of endothelial intestinal barrier |
GO_0070944 | Biological process | neutrophil-mediated killing of bacterium |
GO_0140052 | Biological process | cellular response to oxidised low-density lipoprotein particle stimulus |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0002283 | Biological process | neutrophil activation involved in immune response |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0014075 | Biological process | response to amine |
GO_0002269 | Biological process | leukocyte activation involved in inflammatory response |
GO_0042832 | Biological process | defense response to protozoan |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0002238 | Biological process | response to molecule of fungal origin |
GO_0051607 | Biological process | defense response to virus |
GO_2000341 | Biological process | regulation of chemokine (C-X-C motif) ligand 2 production |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0006338 | Biological process | chromatin remodeling |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0014004 | Biological process | microglia differentiation |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042742 | Biological process | defense response to bacterium |
GO_0070935 | Biological process | 3'-UTR-mediated mRNA stabilization |
GO_0006915 | Biological process | apoptotic process |
GO_0009682 | Biological process | induced systemic resistance |
GO_0031234 | Cellular component | extrinsic component of cytoplasmic side of plasma membrane |
GO_0009986 | Cellular component | cell surface |
GO_0010008 | Cellular component | endosome membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019897 | Cellular component | extrinsic component of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005149 | Molecular function | interleukin-1 receptor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005121 | Molecular function | Toll binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0035325 | Molecular function | Toll-like receptor binding |
GO_0070976 | Molecular function | TIR domain binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0140674 | Molecular function | ATP-dependent histone chaperone activity |
GO_0005515 | Molecular function | protein binding |
GO_0005123 | Molecular function | death receptor binding |
Gene name | MYD88 |
Protein name | Myeloid differentiation primary response 88 Myeloid differentiation primary response protein MyD88 Mutant myeloid differentiation primary response 88 |
Synonyms | |
Description | FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response . Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response . Increases IL-8 transcription . Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation . MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity). . FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response. . FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response. . |
Accessions | ENST00000417037.8 [Q99836-2] A0A8V8TP38 ENST00000651800.2 [Q99836-3] A0A192GQD4 A0A192GP51 A0A3F2YP85 ENST00000650905.2 [Q99836-1] ENST00000699086.1 ENST00000417037 ENST00000650112.2 [Q99836-4] A0A3B3ITY3 ENST00000650112 A0A494C0J8 A0A193CK37 ENST00000652213.1 ENST00000421516.3 [Q99836-6] A0A192GQL6 ENST00000651800 A0A0A0MSI9 Q99836 |